Celyad Oncology Investor Relations Material
Latest events
H1 2023
Celyad Oncology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Celyad Oncology SA
Access all reports
Celyad Oncology SA is a Belgium-based clinical-stage biotechnology company focused on the development of cell therapy solutions for cancer. The company specializes in chimeric antigen receptor T-cell (CAR-T) therapies, leveraging proprietary technologies to develop allogeneic and autologous approaches for the treatment of solid and hematologic tumors. Celyad Oncology conducts research and clinical trials in collaboration with academic and industry partners. The company is headquartered in Mont-Saint-Guibert, Belgium, and its shares are listed on the Euronext Brussels and the NASDAQ.
)
)
)